Show simple item record

dc.creatorRobert, Alexis
dc.date.accessioned2020-10-16T20:40:04Z
dc.date.available2020-10-16T20:40:04Z
dc.date.created2020
dc.identifier.issn0140-6736spa
dc.identifier.otherhttps://doi.org/10.1016/spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/14543
dc.description.abstractIn the absence of a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or of highly effective pharmaceutical treatments for COVID-19, countries have implemented a large range of nonpharmaceutical interventions to control the spread of the virus.1 These interventions differ in their level of stringency (ie, the severity of the measures) and their ultimate objective (eg, prevent health systems being overwhelmed, suppress incidence to low levels, or reduce incidence to zero and keep it there). With many countries facing epidemic resurgence, evaluating the impact of different strategies implemented in the early phases of the pandemic is crucial for developing an effective long-term responsespa
dc.format.extent2 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherThe Lancetspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subjectNew Zealandspa
dc.titleLessons from New Zealand’s COVID-19 outbreak responsespa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record